Citation

Li X, Payne DT, Ampolu B, Bland N, Brown JT, Dutton MJ, Fitton CA, Gulliver A, Hale L, Hamza D, Jones G, Lane R, Leach AG, Male L, Merisor EG, Morton MJ, Quy AS, Roberts R, Scarll R, Schulz-Utermoehl T, Stankovic T, Stevenson B, Fossey JS, Agathanggelou A.: Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia. Medchemcomm, Volume 10 (8), 2019

Authors

Agathanggelou A., Ampolu B, Bland N, Brown JT, Dutton MJ, Fitton CA, Fossey JS, Gulliver A, Hale L, Hamza D, Jones G, Lane R, Leach AG, Li X, Male L, Merisor EG, Morton MJ, Payne DT, Quy AS, Roberts R, Scarll R, Schulz-Utermoehl T, Stankovic T, Stevenson B

Journal

Medchemcomm

Year

2019

DOI

10.1039/c9md00297a

PubMed

32952998

Machine-readable

REST APIRDF